CN1055009C - Chinese patent drug for treatment of diabetes mellitus - Google Patents
Chinese patent drug for treatment of diabetes mellitus Download PDFInfo
- Publication number
- CN1055009C CN1055009C CN97104073A CN97104073A CN1055009C CN 1055009 C CN1055009 C CN 1055009C CN 97104073 A CN97104073 A CN 97104073A CN 97104073 A CN97104073 A CN 97104073A CN 1055009 C CN1055009 C CN 1055009C
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese patent
- patent medicine
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 15
- 229940079593 drug Drugs 0.000 title description 11
- 210000002826 placenta Anatomy 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims description 12
- 239000008517 radix Trichosanthis Substances 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 239000009286 sanguis draxonis Substances 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 6
- 241000219780 Pueraria Species 0.000 claims description 3
- 241001530126 Scrophularia Species 0.000 claims description 3
- 239000007963 capsule composition Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 19
- 210000004369 blood Anatomy 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 230000001717 pathogenic effect Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000209020 Cornus Species 0.000 abstract 1
- 240000007371 Cuscuta campestris Species 0.000 abstract 1
- 241001523681 Dendrobium Species 0.000 abstract 1
- 235000005903 Dioscorea Nutrition 0.000 abstract 1
- 244000281702 Dioscorea villosa Species 0.000 abstract 1
- 235000000504 Dioscorea villosa Nutrition 0.000 abstract 1
- 240000002045 Guettarda speciosa Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 241000218989 Trichosanthes Species 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000002124 endocrine Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000001035 drying Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a Chinese patent medicine for treating diabetes mellitus. The Chinese patent medicine is an oral administration Chinese patent medicine prepared from 16 traditional Chinese medicine materials of astragali, American ginseng, cornus fruit, dodder, placenta, fruit of Chinese magnoliavine, angelica, dragon's blood, red sage root, trichosanthes root, dendrobium, figwort, tuber of dwarf lilyturf, raw dioscorea root, radix rehmanniae and kudzu root according to prescription principles of benefiting vital energy, nourishing yin, strengthening body resistance, eliminating pathogenic factors, cooling blood, promoting blood circulation, clearing heat and eliminating dampness. The Chinese patent medicine has the advantages of treatment of both the manifestation and the root cause of diseases, conspicuous clinical curative effect, high effective rate and no toxic or side effect.
Description
The invention belongs to a kind of oral Chinese patent medicine for the treatment of diabetes.
Diabetes are the doctor trained in Western medicine name of disease, and the traditional Chinese medical science is called diabetes, and domestic sickness rate is about about 0.7%, and obvious ascendant trend is arranged.Though the medicine of western medical treatment primary disease is a lot of at present, curative effect is not consolidated, and primary disease belongs to a kind of systemic disease, and the traditional Chinese medical science also has many medicines, and is each has something to recommend him, but generally speaking still belong to a kind of disease of refractory.
The present invention aims to provide a kind of malicious pair and does little and can obtain the oral Chinese patent medicine of the treatment diabetes of better curative effect.
The technical scheme that realizes above-mentioned purpose is that raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are (consumption is a weight portion):
Radix Astragali 25-35 part Radix Panacis Quinquefolii 25-35 part Fructus Corni 17-23 part Semen Cuscutae 12-18 part
Placenta Hominis 17-23 part Fructus Schisandrae Chinensis 10-14 part Radix Angelicae Sinensis 10-14 part Sanguis Draxonis 4-6 part
Radix Salviae Miltiorrhizae 10-14 part Radix Trichosanthis 25-35 part Herba Dendrobii 12-18 part Radix Scrophulariae 17-23 part
Radix Ophiopogonis 10-14 part Rhizoma Dioscoreae 17-23 part Radix Rehmanniae 17-23 part Radix Puerariae 12-18 part
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
Diabetes are that due to endocrine regulation was lacked of proper care, its clinical manifestation mainly was that blood stasis is scorching because a variety of causes causes immune function of human body to descend.It is considered herein that and answer treating both the principal and secondary aspects of a disease can obtain desirable curative effect that aspect effecting a permanent cure, resets mends " kidney ", " gas " of human body, improve the endocrine ability of self regulation, aspect taking stopgap measures, then, improve symptom at diabetes patient's " dry ", " wetting ", " stasis of blood " clinically.Therefore our with supplementing QI and nourishing YIN, strengthening vital QI to eliminate pathogenic factors, removing heat from blood and promoting blood circulation, heat clearing and damp drying are the principles of formulating prescriptions.The Radix Astragali, Radix Panacis Quinquefolii, Fructus Corni, Semen Cuscutae, Placenta Hominis have the kidney tonifying QI invigorating in the side, improve the organism endocrine regulatory function, Radix Panacis Quinquefolii is wherein mended and not dry, and Fructus Corni can improve immunologic function, Placenta Hominis has endocrine regulation and hormone-like effect, and these a few flavor medicines have blood sugar reducing function more;
Radix Angelicae Sinensis has remarkable increase coronary flow and blood vessel dilating effect in the side, and can effectively suppress the anaerobic condition of tissue, Sanguis Draxonis is the Chinese medicine tradition stasis-breaking drug of invigorating blood circulation, modern age, pharmacological research confirmed to have the blood circulation of improvement and blood sugar reducing function, Radix Salviae Miltiorrhizae is drug for invigorating blood circulation and eliminating stasis commonly used, and three flavors play blood circulation promoting and blood stasis dispelling altogether, improve the blood circulation effect;
Fructus Schisandrae Chinensis, Radix Trichosanthis, Herba Dendrobii, Radix Scrophulariae, Radix Ophiopogonis, Rhizoma Dioscoreae, the Radix Rehmanniae, Radix Puerariae are the medicine of heat clearing and damp drying yin nourishing removing heat from blood in the side, and Radix Trichosanthis wherein, Radix Ophiopogonis, the Radix Rehmanniae, Rhizoma Dioscoreae still have blood sugar reducing function.
Full side ten Six-element medicines cooperate the effect of playing supplementing QI and nourishing YIN, strengthening vital QI to eliminate pathogenic factors, removing heat from blood and promoting blood circulation, heat clearing and damp drying.
Clinical analysis
The criterion of therapeutical effect that reference " technological guidance's principle of new Chinese medicine treatment diabetes clinical research " and nineteen eighty-two whole nation diabetes meeting are drafted, the comprehensive therapeutic effect evaluation is carried out in medication after 60 days.Including 316 cases of statistics in, is the complete type ii diabetes patient of observed and recorded (the type i diabetes people does not list scope of statistics in).A, 316 routine type ii diabetes people blood sugar lowering curative effect statistical tables (by the blood sugar level statistics)
Total effective 288 people of this group case blood sugar lowering, effective percentage 91.2% is controlled undesirable person 28 people, inefficiency 8.8%.
| Curative effect | Produce effects enabledisable subtotal |
| Example number % | 114 174 28 316 36.1 55.1 8.8 100 |
B, 316 routine diabetes patient's clinical symptoms are improved statistical table
| Symptom | Before the treatment | After the treatment | ||
| Example number % | It is invalid that produce effects takes a turn for the better | |||
| Example number % | Example number % | Example number % | ||
| The polydipsia polyuria polyphagia scorching itching over the body edema of becoming thin is unable | 298 94.3 270 85.4 192 60.7 176 55.7 264 83.5 253 46.2 | 156 52.3 161 59.6 73 38 152 86.4 138 60 186 58.9 | 140 47.1 106 39.3 107 61 24 13.6 126 40 67 41.1 | 2 6 3 1.1 4 1 0 0 0 0 0 0 |
More than statistics as can be known, clinical symptoms all is significantly improved after the medication, and is particularly unable etc. all effectively to scorching itching over the body, edema.
Model case
1, Wang Li spends the accounting of 56 years old Xinjiang of woman Urumqi City building constructor
On May 27th, 94 examined, and the patient claimed to suffer from diabetes 5 years, once obeyed multiple blood sugar lowering Western medicine, the blood sugar urinary sugar horizontal instability, and every day, brothers' heart burnt, and it is unable to become thin, and looks into patient's blood glucose 14.6mmol/L glucose in urine (+++), rolling pulse, yellow fur.Advise this beneficial sugared capsule for eliminating of clothes, every day three times, each 9, symptom is obviously improved after two weeks of medication, and brothers' heart burns and stops substantially, and thirsty and hunger sensation alleviates, the efficacy consolidation in January of taking medicine again, the Western medicine of all stopping using.Check on July 6, fasting glucose has been reduced to normally, and glucose in urine (-) is evident in efficacy.
2, Li Lianying, man, 64 years old, Chengdu, the Sichuan retired staff of bank.Examine March 27 nineteen ninety-five, claim to suffer from diabetes 12 years, once used multiple in, western medicine, the state of an illness is repeatedly recently, glucose in urine is frequent +++extremely ++ ++, polyuria, polydipsia, malaise, skin pruritus is advised the sugared capsule for eliminating of this medicine of clothes benefit, every day three times, each 9, the further consultation in month of taking medicine, thirsty and pruritus symptom alleviates, and blood glucose is reduced to 7.6mmol/L, glucose in urine (+), take medicine January, all diseases disappear entirely again, and blood glucose, glucose in urine are reduced to normal level.
This Chinese patent medicine treating both the principal and secondary aspects of a disease, clinical efficacy is remarkable, and the effective percentage height has no side effect.
The embodiment explanation
Embodiment 1
Every dose of raw material of Chinese medicine that is adopted of this routine Chinese patent medicine and weight proportion are:
Radix Astragali 30g Radix Panacis Quinquefolii 30g Fructus Corni 20g Semen Cuscutae 15g
The Placenta Hominis 20g 12g Radix Angelicae Sinensis 12g Sanguis Draxonis 5g that distinguishes the flavor of
Radix Salviae Miltiorrhizae 12g Radix Trichosanthis 30g Herba Dendrobii 15g Radix Scrophulariae 20g
Radix Ophiopogonis 12g Rhizoma Dioscoreae 20g Radix Rehmanniae 20g Radix Puerariae 15g
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation;
Manufacture method: elder generation chooses decontamination with above-mentioned 16 flavor medicines, is ground into fine powder, crosses 100 mesh sieves, gets final product in the 0.5g capsule of again medicated powder being packed into, with cobalt 60 radiation sterilizations, with favorable moth-proof or fungus growth, can make the interior preservation of capsule 2-3 good.
Instructions of taking is obeyed three every day, and according to year order and state of an illness clothes 6-9 grain (3-4.5g), medication 30 days was a course of treatment at every turn, and the period in a medicine patient must control high-carbohydrate food, cooperates moderate exercise, formerly takes blood sugar lowering Western medicine person and withdraws gradually.
Embodiment 2
Raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are:
12 parts of 17 parts of Semen Cuscutae of 35 parts of Fructus Corni of 35 parts of Radix Panacis Quinquefoliis of the Radix Astragali
4 parts of 10 parts of Sanguis Draxonis of 14 parts of Radix Angelicae Sinensis of 23 parts of Fructus Schisandrae Chinensis of Placenta Hominis
17 parts of 12 portions of Radix Scrophulariaes of 35 parts of Herba Dendrobiis of 14 parts of Radix Trichosanthis of Radix Salviae Miltiorrhizae
12 parts of 17 parts of Radix Puerariaes of 23 parts of Radix Rehmanniae of 14 parts of Rhizoma Dioscoreae Radix Ophiopogonis
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
Embodiment 3
Raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are:
18 parts of 23 parts of Semen Cuscutae of 25 parts of Fructus Corni of 25 parts of Radix Panacis Quinquefoliis of the Radix Astragali
6 parts of 14 parts of Sanguis Draxonis of 10 parts of Radix Angelicae Sinensis of 17 parts of Fructus Schisandrae Chinensis of Placenta Hominis
23 parts of 18 portions of Radix Scrophulariaes of 25 parts of Herba Dendrobiis of 10 parts of Radix Trichosanthis of Radix Salviae Miltiorrhizae
18 parts of 23 parts of Radix Puerariaes of 17 parts of Radix Rehmanniae of 10 parts of Rhizoma Dioscoreae Radix Ophiopogonis
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
Claims (2)
1, a kind of Chinese patent medicine for the treatment of diabetes is characterized in that, raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are:
Radix Astragali 25-35 part Radix Panacis Quinquefolii 25-35 part Fructus Corni 17-23 part Semen Cuscutae 12-18 part
Placenta Hominis 17-23 part Fructus Schisandrae Chinensis 10-14 part Radix Angelicae Sinensis 10-14 part Sanguis Draxonis 4-6 part
Radix Salviae Miltiorrhizae 10-14 part Radix Trichosanthis 25-35 part Herba Dendrobii 12-18 part Radix Scrophulariae 17-23 part
Radix Ophiopogonis 10-14 part Rhizoma Dioscoreae 17-23 part Radix Rehmanniae 17-23 part Radix Puerariae 12-18 part
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
2, Chinese patent medicine according to claim 1 is characterized in that, raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are:
15 parts of 20 parts of Semen Cuscutae of 30 parts of Fructus Corni of 30 parts of Radix Panacis Quinquefoliis of the Radix Astragali
5 parts of 12 parts of Sanguis Draxonis of 12 parts of Radix Angelicae Sinensis of 20 parts of Fructus Schisandrae Chinensis of Placenta Hominis
20 parts of 15 portions of Radix Scrophulariaes of 30 parts of Herba Dendrobiis of 12 parts of Radix Trichosanthis of Radix Salviae Miltiorrhizae
15 parts of 20 parts of Radix Puerariaes of 20 parts of Radix Rehmanniae of 12 parts of Rhizoma Dioscoreae Radix Ophiopogonis
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97104073A CN1055009C (en) | 1997-04-25 | 1997-04-25 | Chinese patent drug for treatment of diabetes mellitus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97104073A CN1055009C (en) | 1997-04-25 | 1997-04-25 | Chinese patent drug for treatment of diabetes mellitus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1164413A CN1164413A (en) | 1997-11-12 |
| CN1055009C true CN1055009C (en) | 2000-08-02 |
Family
ID=5167110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97104073A Expired - Fee Related CN1055009C (en) | 1997-04-25 | 1997-04-25 | Chinese patent drug for treatment of diabetes mellitus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1055009C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102743599A (en) * | 2012-07-05 | 2012-10-24 | 许瑞琴 | Traditional Chinese medicine for treating diabetes |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100335080C (en) * | 2003-12-12 | 2007-09-05 | 陈永军 | Medication for treating diabetes |
| WO2006117566A2 (en) * | 2005-05-03 | 2006-11-09 | Ultra Biotech Limited | Botanical anticancer formulations |
| CN100443103C (en) * | 2006-11-10 | 2008-12-17 | 广西中医学院 | A kind of pharmaceutical composition for treating diabetic complications and preparation method thereof |
| CN104491529A (en) * | 2014-12-16 | 2015-04-08 | 济南方宇文化传媒有限公司 | Traditional Chinese medicine granule for treating II diabetes and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1124154A (en) * | 1995-03-30 | 1996-06-12 | 随嫣玲 | Traditional Chinese medicine for effectively curing diabetes and preparing method |
-
1997
- 1997-04-25 CN CN97104073A patent/CN1055009C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1124154A (en) * | 1995-03-30 | 1996-06-12 | 随嫣玲 | Traditional Chinese medicine for effectively curing diabetes and preparing method |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102743599A (en) * | 2012-07-05 | 2012-10-24 | 许瑞琴 | Traditional Chinese medicine for treating diabetes |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1164413A (en) | 1997-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101224287B (en) | Oral administration Chinese traditional medicine for treating acne and preparing method thereof | |
| CN101049415A (en) | Preparation of Chinese traditional medicine for treating inflammation of department of gynecology | |
| CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
| CN101745078B (en) | Chinese medicinal composition for treating cardiac failure and preparation method thereof | |
| CN101411826A (en) | Internal-use medicament for treating psoriasis | |
| CN102552761A (en) | Chinese medicinal pills for treating psoriasis | |
| CN1055009C (en) | Chinese patent drug for treatment of diabetes mellitus | |
| CN102000238B (en) | Jiulong capsule and its preparation method | |
| CN1055226C (en) | Medicine for curing trichomadesis and its preparation method | |
| CN105232958B (en) | Traditional Chinese medicine composition for preparing medicine for treating myasthenia gravis | |
| CN108186967A (en) | One kind keeps fit and healthy health-preserving medicinal liquor and preparation method thereof | |
| CN105770515A (en) | Traditional Chinese medicinal composition for treating prostatitis and preparation method of traditional Chinese medicinal composition | |
| CN101618172A (en) | Traditional Chinese medicine for treating hepatitis B, cirrhosis, liver cancer and liver ascites | |
| CN101085165A (en) | Internal-applied traditional Chinese medicine composition for treating viral myocarditis | |
| CN105412621A (en) | Method for preparing pharmaceutical composition for treating hemorrhoids | |
| CN1233409C (en) | Combination of Chinese traditional medicine for health preservation and preparation method | |
| CN1094368C (en) | Chinese medicine for treating alopecia | |
| CN104606600A (en) | Traditional Chinese medicine composition for treating interstitial lung disease and preparation method of composition | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN109331152A (en) | A kind of Chinese medicine composition for treating vasculitis | |
| CN1179743C (en) | Sore-eliminating medicine powder and its prepn and usage | |
| CN1242198A (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN105311419A (en) | Traditional Chinese medicine composition for treating oral inflammations and preparation method thereof | |
| CN121371082A (en) | A traditional Chinese medicine composition for preventing and treating chronic heart failure of the Yang deficiency, blood stasis, and water retention type and its application. | |
| CN105749232A (en) | Folium artemisiae argyi-containing traditional Chinese medicine formula for tonifying kidney yang and nourishing kidney yin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |